Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K, Tanabe Y, Kubota D, Akaike K, Hayashi T, Mogushi K, Hosoya M, Sato S, Kobayashi E, Okubo T, Kim Y, Kohsaka S, Saito T, Kaneko K, Suehara Y. Mukaihara K, et al. PLoS One. 2017 Sep 25;12(9):e0185321. doi: 10.1371/journal.pone.0185321. eCollection 2017. PLoS One. 2017. PMID: 28945796 Free PMC article.
Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
Mukaihara K, Suehara Y, Kohsaka S, Akaike K, Tanabe Y, Kubota D, Ishii M, Fujimura T, Kazuno S, Okubo T, Takagi T, Yao T, Kaneko K, Saito T. Mukaihara K, et al. PLoS One. 2016 Feb 10;11(2):e0148401. doi: 10.1371/journal.pone.0148401. eCollection 2016. PLoS One. 2016. PMID: 26863138 Free PMC article.
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Tanabe Y, Suehara Y, Kohsaka S, Hayashi T, Akaike K, Mukaihara K, Kurihara T, Kim Y, Okubo T, Ishii M, Kazuno S, Kaneko K, Saito T. Tanabe Y, et al. Among authors: mukaihara k. Oncotarget. 2018 Feb 12;9(18):14428-14443. doi: 10.18632/oncotarget.24467. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581854 Free PMC article.
PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.
Akaike K, Suehara Y, Kohsaka S, Hayashi T, Tanabe Y, Kazuno S, Mukaihara K, Toda-Ishii M, Kurihara T, Kim Y, Okubo T, Hayashi Y, Takamochi K, Takahashi F, Kaneko K, Ladanyi M, Saito T. Akaike K, et al. Among authors: mukaihara k. Oncotarget. 2018 May 18;9(38):25206-25215. doi: 10.18632/oncotarget.25392. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861864 Free PMC article.
43 results